Dana-Farber CEO Laurie Glimcher talks her risk-filled career

Glimcher is taking what may be the greatest risk of her career: breaking up a decades-long partnership with Brigham & Women’s Hospital and inking a deal for with Beth Israel Deaconess Medical Center to build a 300-bed Dana-Farber cancer hospital.

Related Keywords

Back Bay ,Massachusetts ,United States ,Dana Farber Cancer Institute ,Brookline ,Harvard School Of Public Health ,Boston ,Edward Benz Jr ,Hugh Auchincloss ,Glimcher Harvard ,Jake Auchincloss ,Craigf Walker ,Josh Bekenstein ,Weill Cornell ,Carl Nathan ,Lora Pellegrini ,Davidl Ryan ,Sandy Weill ,Bristol Myers Squibb ,Melvin Glimcher ,Anne Klibanski ,Kevin Tabb ,Laurie Glimcher ,Barrett Rollins ,Susanne Szabo ,Citigroup ,National Academy Of Medicine ,National Institutes Of Health ,Analog Devices ,National Academy Of Sciences ,Massachusetts Association Of Health ,Waters Corp ,Drug Administration ,Harvard Medical School ,Joslin Diabetes Center ,Beth Israel Deaconess Medical Center ,Beth Israel Lahey Health ,Mass General Brigham ,Longwood Medical ,Beth Israel Lahey ,Quin House ,Massachusetts General Hospital ,Boston Children ,National Institutes ,Harvard School ,Public Health ,National Academy ,Dana Farber Cancer ,Joslin Diabetes ,Beth Israel ,Massachusetts Association ,Health Plans , ,